These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34439359)

  • 1. A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis.
    Sereno M; Jimenez-Gordo AM; Baena-Espinar J; Aguado C; Mielgo X; Pertejo A; Álvarez-Álvarez R; Sánchez A; López JL; Molina R; López-Alfonso A; Hernández B; Chiara LE; Martín AM; López-Martín A; Dorta M; Collazo-Lorduy A; Casado E; de Molina AR; Colmenarejo G
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutropenic complications in advanced-stage non-Hodgkin's lymphoma: implications for the use of prophylactic recombinant human granulocyte-colony stimulating factor (G-CSF).
    Bobey N; Woodman RC
    Clin Invest Med; 1998 Apr; 21(2):63-70. PubMed ID: 9562926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-CSF and GM-CSF for treating or preventing neonatal infections.
    Carr R; Modi N; Doré C
    Cochrane Database Syst Rev; 2003; 2003(3):CD003066. PubMed ID: 12917944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does granulocyte colony-stimulating factor affect survival in patients with advanced non-small cell lung cancer?
    Kasymjanova G; Kreisman H; Correa JA; Dajczman E; Small D
    J Thorac Oncol; 2006 Jul; 1(6):564-70. PubMed ID: 17409918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Neutropenia and Filgrastim (G-CSF) in Cancer Patients With COVID-19 Infection.
    Morjaria S; Zhang A; Kaltsas Md A; Parameswaran R; Patel D; Zhou W; Predmore J; Perez Johnston R; Jee J; Perales M; Daniyan A; Taur Y; Mailankody S
    medRxiv; 2020 Aug; ():. PubMed ID: 32817981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prophylactic colony-stimulating factors for the prevention of chemotherapy-induced febrile neutropenia in breast cancer patients.
    Renner P; Milazzo S; Liu JP; Zwahlen M; Birkmann J; Horneber M
    Cochrane Database Syst Rev; 2012 Oct; 10():CD007913. PubMed ID: 23076939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor use in neutropenic patients infected with human immunodeficiency virus.
    Ambati BK; Perlman DC; Salomon N
    Int J Infect Dis; 1998-1999 Winter; 3(2):70-5. PubMed ID: 10225983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.
    Mayordomo JI; Rivera F; Díaz-Puente MT; Lianes P; Colomer R; López-Brea M; López E; Paz-Ares L; Hitt R; García-Ribas I
    J Natl Cancer Inst; 1995 Jun; 87(11):803-8. PubMed ID: 7540696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suboptimal duration of granulocyte colony-stimulating factor use and chemotherapy-induced neutropenia in women diagnosed with breast cancer.
    Lin WT; Wen YW; Chien CR; Gau CS; Chiang SC; Hsiao FY
    Clin Ther; 2014 Sep; 36(9):1287-94. PubMed ID: 25130388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte colony-stimulating factor and respiratory status of critically ill neutropenic patients with hematologic malignancies.
    Mignard X; Biard L; Lemiale V; Mokart D; Pène F; Kouatchet A; Mayaux J; Vincent F; Nyunga M; Bruneel F; Rabbat A; Lebert C; Perez P; Meert AP; Benoit D; Hamidfar R; Darmon M; Azoulay E; Zafrani L
    Leuk Lymphoma; 2019 May; 60(5):1156-1163. PubMed ID: 30277108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer.
    Liang DC
    Paediatr Drugs; 2003; 5(10):673-84. PubMed ID: 14510625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte colony-stimulating factor use is associated with decreased bacteremia and increased survival in neutropenic HIV-infected patients.
    Keiser P; Rademacher S; Smith JW; Skiest D; Vadde V
    Am J Med; 1998 Jan; 104(1):48-55. PubMed ID: 9528719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic use of granulocyte colony-stimulating factors for established febrile neutropenia: effect on costs from a hospital perspective.
    Cosler LE; Eldar-Lissai A; Culakova E; Kuderer NM; Dale D; Crawford J; Lyman GH
    Pharmacoeconomics; 2007; 25(4):343-51. PubMed ID: 17402806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of benefit of granulocyte macrophage or granulocyte colony stimulating factor in patients with febrile neutropenia.
    Siddiqui T; Burney IA; Kakepoto GN; Khurshid M; Salam A; Smego RA
    J Pak Med Assoc; 2002 May; 52(5):206-10. PubMed ID: 12174492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colony-stimulating factors for the management of neutropenia in cancer patients.
    Dale DC
    Drugs; 2002; 62 Suppl 1():1-15. PubMed ID: 12479591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer.
    Repetto L; Biganzoli L; Koehne CH; Luebbe AS; Soubeyran P; Tjan-Heijnen VC; Aapro MS
    Eur J Cancer; 2003 Nov; 39(16):2264-72. PubMed ID: 14556916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.
    Rusthoven J; Bramwell V; Stephenson B
    Cancer Prev Control; 1998 Aug; 2(4):179-90. PubMed ID: 10093631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death.
    Yarza R; Bover M; Paredes D; López-López F; Jara-Casas D; Castelo-Loureiro A; Baena J; Mazarico JM; Folgueira MD; Meléndez-Carmona MÁ; Reyes A; Lumbreras C; Paz-Ares L; Díaz-Pedroche C; Gómez-Martín C
    Eur J Cancer; 2020 Aug; 135():242-250. PubMed ID: 32586724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention and treatment of febrile neutropenia].
    Montemurro F; Gallicchio M; Aglietta M
    Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of colony-stimulating factors for febrile neutropenia: a retrospective study.
    Tan H; Tomic K; Hurley D; Daniel G; Barron R; Malin J
    Curr Med Res Opin; 2011 Jan; 27(1):79-86. PubMed ID: 21091127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.